Elizabeth A. Barlow

7.5k total citations · 1 hit paper
13 papers, 5.7k citations indexed

About

Elizabeth A. Barlow is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Elizabeth A. Barlow has authored 13 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Elizabeth A. Barlow's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (4 papers). Elizabeth A. Barlow is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (4 papers). Elizabeth A. Barlow collaborates with scholars based in United States, France and Germany. Elizabeth A. Barlow's co-authors include Frances K. Stage, James B. Schreiber, Amaury Nora, Jamie M. King, Shannon C. Kenney, Stacy R. Hagemeier, Meng Qiao, Jillian A. Bristol, Eric Johannsen and Shidong Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and International Journal of Cancer.

In The Last Decade

Elizabeth A. Barlow

13 papers receiving 5.4k citations

Hit Papers

Reporting Structural Equation Modeling and Confirmatory F... 2006 2026 2012 2019 2006 1000 2.0k 3.0k 4.0k 5.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth A. Barlow United States 13 1.2k 1.1k 1.1k 929 596 13 5.7k
Mike W.‐L. Cheung Singapore 46 1.7k 1.3× 1.9k 1.7× 1.6k 1.5× 788 0.8× 1.4k 2.3× 104 9.5k
Sehee Hong South Korea 18 1.4k 1.1× 1.4k 1.3× 1.2k 1.1× 1.1k 1.2× 849 1.4× 87 6.2k
Rob Turrisi United States 44 1.4k 1.1× 1.9k 1.7× 1.9k 1.8× 664 0.7× 655 1.1× 212 10.8k
Pere J. Ferrando Spain 34 1.5k 1.3× 1.7k 1.5× 738 0.7× 805 0.9× 900 1.5× 190 5.6k
James B. Schreiber United States 22 1.6k 1.3× 1.7k 1.5× 1.4k 1.3× 1.5k 1.6× 820 1.4× 95 7.4k
Amanda J. Fairchild United States 23 1.7k 1.4× 2.3k 2.0× 1.5k 1.4× 771 0.8× 1.0k 1.7× 70 8.1k
Leslie A. Hayduk Canada 35 1.5k 1.2× 1.1k 1.0× 1.7k 1.6× 921 1.0× 747 1.3× 84 7.7k
Murray Smith United Kingdom 16 1.8k 1.5× 1.7k 1.5× 1.5k 1.4× 850 0.9× 858 1.4× 64 7.2k
Jamie M. King United States 3 1.2k 1.0× 1.1k 1.0× 1.1k 1.0× 945 1.0× 596 1.0× 7 5.2k
Jennifer P. Wisdom United States 28 982 0.8× 1.5k 1.4× 1.4k 1.3× 786 0.8× 193 0.3× 100 9.0k

Countries citing papers authored by Elizabeth A. Barlow

Since Specialization
Citations

This map shows the geographic impact of Elizabeth A. Barlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Barlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Barlow more than expected).

Fields of papers citing papers by Elizabeth A. Barlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Barlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Barlow. The network helps show where Elizabeth A. Barlow may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Barlow

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Barlow. A scholar is included among the top collaborators of Elizabeth A. Barlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Barlow. Elizabeth A. Barlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hawk, Cheryl, Ronald J. Farabaugh, Clinton J. Daniels, et al.. (2020). Best Practices for Chiropractic Management of Patients with Chronic Musculoskeletal Pain: A Clinical Practice Guideline. The Journal of Alternative and Complementary Medicine. 26(10). 884–901. 29 indexed citations
2.
Romero-Masters, James C., Shane M. Huebner, Makoto Ohashi, et al.. (2020). B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PLoS Pathogens. 16(2). e1008365–e1008365. 31 indexed citations
3.
Bristol, Jillian A., Carrie B. Coleman, Makoto Ohashi, et al.. (2018). A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathogens. 14(7). e1007179–e1007179. 76 indexed citations
4.
Bilger, Andrea, Shidong Ma, Dhananjay M. Nawandar, et al.. (2017). Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication. Oncotarget. 8(27). 44266–44280. 61 indexed citations
5.
Nawandar, Dhananjay M., Makoto Ohashi, Elizabeth A. Barlow, et al.. (2017). Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. Journal of Virology. 91(8). 47 indexed citations
6.
Nawandar, Dhananjay M., Anqi Wang, Kathleen R. Makielski, et al.. (2015). Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells. PLoS Pathogens. 11(10). e1005195–e1005195. 79 indexed citations
7.
Sun, Xiaoping, Jillian A. Bristol, Satoko Iwahori, et al.. (2013). Hsp90 Inhibitor 17-DMAG Decreases Expression of Conserved Herpesvirus Protein Kinases and Reduces Virus Production in Epstein-Barr Virus-Infected Cells. Journal of Virology. 87(18). 10126–10138. 43 indexed citations
8.
Hagemeier, Stacy R., Elizabeth A. Barlow, Meng Qiao, & Shannon C. Kenney. (2012). The Cellular Ataxia Telangiectasia-Mutated Kinase Promotes Epstein-Barr Virus Lytic Reactivation in Response to Multiple Different Types of Lytic Reactivation-Inducing Stimuli. Journal of Virology. 86(24). 13360–13370. 67 indexed citations
9.
Hagemeier, Stacy R., et al.. (2011). The Epstein-Barr Virus BRRF1 Protein, Na, Induces Lytic Infection in a TRAF2- and p53-Dependent Manner. Journal of Virology. 85(9). 4318–4329. 31 indexed citations
10.
Sun, Xiaoping, Elizabeth A. Barlow, Shidong Ma, et al.. (2010). Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proceedings of the National Academy of Sciences. 107(7). 3146–3151. 63 indexed citations
11.
Bristol, Jillian A., et al.. (2010). The Epstein-Barr Virus BZLF1 Protein Inhibits Tumor Necrosis Factor Receptor 1 Expression through Effects on Cellular C/EBP Proteins. Journal of Virology. 84(23). 12362–12374. 15 indexed citations
12.
Jones, Richard J., William T. Seaman, Elizabeth A. Barlow, et al.. (2007). Roles of lytic viral infection and IL‐6 in early versus late passage lymphoblastoid cell lines and EBV‐associated lymphoproliferative disease. International Journal of Cancer. 121(6). 1274–1281. 50 indexed citations
13.
Schreiber, James B., Amaury Nora, Frances K. Stage, Elizabeth A. Barlow, & Jamie M. King. (2006). Reporting Structural Equation Modeling and Confirmatory Factor Analysis Results: A Review. The Journal of Educational Research. 99(6). 323–338. 5107 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026